# Yu‐Tzu Tai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yu-tzu-tai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,272 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 87 |
| i10-index | 203 |
| OpenAlex ID | https://openalex.org/A5019802024 |
| ORCID iD | https://orcid.org/0000-0001-6199-3569 |
| Works | 735 |

## Researcher papers

- [Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu](https://scholariq.org/papers/anti-cs1-humanized-monoclonal-antibody-huluc63-inhibits-myeloma-cell-adhesion/)
- [Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma](https://scholariq.org/papers/blockade-of-xbp1-splicing-by-inhibition-of-ire1-is-a-promising-therapeutic/)
- [Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma](https://scholariq.org/papers/biallelic-loss-of-bcma-as-a-resistance-mechanism-to-car-t-cell-therapy-in-a/)
- [A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma](https://scholariq.org/papers/a-novel-aurora-a-kinase-inhibitor-mln8237-induces-cytotoxicity-and-cell-cycle/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Chromatin Remodeling and Cancer](https://scholariq.org/topics/chromatin-remodeling-and-cancer/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.